Multidisciplinary approach to treatment of advanced gastric cancer


Cite item

Full Text

Abstract

This arcticle presents possibilities of combined treatment of a patient with advanced gastric cancer. The patient with gastric cancer and hepatic, paragastric and left supraclavicular metastases was treated by chemotherapy. 8 courses of chemotherapy by docetaxel + cisplatin + 5-fluorouracil + leucovorin resulted in complete regression of distant metastases. This allowed conducting D2 subtotal gastric resection in the patient. Morphologic examination of the tissue samples obtained during surgery identified a low-differetiated gastric adenocarcinoma infiltrating gastric wall to the subserous layer. No metastases were detected in locoregional lymph nodes. Adjuvant chemotherapy was discontinued after 2 courses because of increasing neuropathy. Over the follow up period no disease progression has been registered by April 2015. The overall survival reached 67 months. Thus, combined treatment of the patient resulted in increased overall survival.

About the authors

Elena V. Trusilova

N.N. Blokhin Russian Cancer Research Center

Email: tev_86@mail.ru
MD, PhD 115478, Moscow, Russian Federation

N. S Besova

N.N. Blokhin Russian Cancer Research Center

115478, Moscow, Russian Federation

S. V Khokhlova

N.N. Blokhin Russian Cancer Research Center

115478, Moscow, Russian Federation

V. A Gorbunova

N.N. Blokhin Russian Cancer Research Center

115478, Moscow, Russian Federation

S. N Nered

N.N. Blokhin Russian Cancer Research Center

115478, Moscow, Russian Federation

I. S Stilidi

N.N. Blokhin Russian Cancer Research Center

115478, Moscow, Russian Federation

References

  1. Социально значимые заболевания населения России в 2013 году. М.; 2014.
  2. Ajani J.A., Moiseyenko V.M., Tjulandin S.A. et al. Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study. J. Clin. Oncol. 2007; 25: 3210-6.
  3. Ajani J.A., Fodor M.B., Tjulandin S.A. et al. Phase II multiinstitutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma. J. Clin. Oncol. 2005; 23(24): 5660-7.
  4. Van Cutsem E., Moiseyenko V.M., Tjulandin S., et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group. J. Clin. Oncol. 2006; 24: 4991-7.
  5. Gorbunova V., Orel N., Besova N. Combined chemotherapy with docetaxel in extensive advanced gastric cancer (pilot study). In: 10th International Congress on Anti-Cancer Treatment. Jan. 31-Feb. 3.2000. Paris; 2000: 270.
  6. Gorbunova V.A., Besova N.S., Orel F. et al. The efficacy and toxicity of Taxoter (T) + Cisplatin (P) + 5-FU (F) (TPF) as the first-line chemotherapy in advanced gastric cancer. Treatment possibilities in the elderly (aged 65 years). Final results. Ann. Oncol. 2004; 14 (Suppl. 3): III63, Abstr. 102.
  7. Трусилова Е.В., Бесова Н.С., Лимарева С.В., Багрова С.Г., Горбунова В.А., Бондаренко Ю.В. Эффективность и токсичность комбинированного режима доцетаксел + цисплатин + лейковорин + 5-фторурацил при диссеминированном раке желудка. Эффективная фармакотерапия. Онкология, гематология, радиология. 2013; 19(2): 5-12.
  8. Трусилова Е.В., Бесова Н.С., Лимарева С.В., Горбунова В.А., Неред С.Н., Стилиди И.С. Успешное комбинированное лечение больного диссеминированным раком желудка. Онкология. Журнал им. П.А. Герцена. 2013; 1: 51-3.
  9. Трусилова Е.В., Бесова Н.С., Багрова С.Г., Горбунова В.А., Стилиди И.С., Неред С.Н. Результаты комбинированного лечения больного диссеминированным раком желудка. Случай из практики. Вопросы онкологии. 2013; 1: 123-5.
  10. Orii T., Karasawa Y., Kitihara H. et al. Long-term survival after sequential chemotherapy and surgery for advanced gastric cancer. Int. J. Surg. Case Rep. 2013; 4(11): 976-80.
  11. Yano M., Shiozaki H., Inoue M. et al. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer. World J. Surg. 2002; 26: 1155-9.

Copyright (c) 2015 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies